| 000 | 01142nom a2200325 u 4500 | ||
|---|---|---|---|
| 001 | 10069459 | ||
| 003 | upatras | ||
| 005 | 20210117201542.0 | ||
| 008 | 090512s2007 eng | ||
| 020 | _a9783540495291 | ||
| 040 |
_aGR-PaULI _cGR-PaULI |
||
| 041 | 0 | _aeng | |
| 100 | 1 |
_aVenitz, J. _964215 |
|
| 245 | 1 | 0 |
_aAppropriate Dose Selection β How to Optimize Clinical Drug Development _h[electronic resource] _cedited by J. Venitz, W. Sittner |
| 260 |
_aBerlin, Heidelberg _bSpringer-Verlag Berlin Heidelberg _c2007 |
||
| 300 | _bv.: digital | ||
| 490 | 0 |
_aErnst Schering Research Foundation Workshop _v59 _x0947-6075 |
|
| 650 | 4 |
_aMedicine _911026 |
|
| 650 | 4 |
_aToxicology _913539 |
|
| 650 | 4 |
_aBiochemistry _910061 |
|
| 650 | 4 |
_aBiomedicine _964032 |
|
| 650 | 4 |
_aPharmacology/Toxicology _964073 |
|
| 650 | 4 |
_aMedicine/Public Health, general _964075 |
|
| 650 | 4 |
_aBiochemistry, general _964024 |
|
| 700 | 1 |
_aSittner, W. _964216 |
|
| 760 | 1 |
_aErnst Schering Research Foundation Workshop _g59 _x0947-6075 |
|
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-540-49529-1 |
| 942 | _2ddc | ||
| 999 |
_c45705 _d45705 |
||